- {{heading}}
- Ab00249-10.0 Anti-Influenza A HA [FLD20]
- H5N1 Influenza A Virus
- Human IgG1
- Purified
- In Stock
- Ab00249-23.0 Anti-Influenza A HA [FLD20]
- H5N1 Influenza A Virus
- Rabbit IgG
- Purified
- In Stock
Recombinant monoclonal antibody to Influenza A HA. Manufactured using AbAb’s Recombinant Platform with variable regions (i.e. specificity) from the EBV transformed human B cell clone FLD20.
Alternative Name(s) of Target: hemagglutinin; haemagglutinin
Immunogen: Made by immortalizing IgG-expressing B cells from patients who had recovered from infections with HPAI H5N1 Viruses.
Specificity: This clone can neutralize the hemagglutinin (HA) of a H5N1 strain of influenza A Virus and has been shown to neutralize both Clade I and Clade II H5N1 viruses.
Antibody first published in: Simmons et al. Prophylactic and therapeutic efficacy of human monoclonal antibodies against H5N1 influenza. PLoS Med. 2007 May;4(5):e178. PMID:17535101